Vancomycin Experience in Physician Office Infusion Centers

Ramesh V. Nathan, MD – Mazur, Statner, Dutta, Nathan, PC, Thousand Oaks, CA
Richard C. Prokesch, MD, FIDSA – Infectious Disease Associates, Riverdale, GA
John S. Adams, MD, FIDSA – Knoxville Infectious Disease Consultants, PC, Knoxville, TN
Quyen Luu, MD – Quyen Luu Infectious Disease, Macon, GA
Kimberly A. Couch, PharmD, MA, FIDSA, FASHP – Healix Infusion Therapy, Inc., Sugar Land, TX
Lucinda J. Van Anglen, PharmD – Healix Infusion Therapy, Inc., Sugar Land, TX

View Poster View Abstract

View All

Phase II and Phase III Studies

Healix regularly and actively supports Phase II and Phase III clinical trials in each of our specialty areas, including active studies in therapies for COVID-19, Multiple Sclerosis and Intestinal Bowel Disease.

For information on partnering with Healix on a study, please contact us.